FDA Plans EUA-Plus Standard For COVID-19 Vaccine, Drafting Guidance

By Beth Wang / September 11, 2020 at 12:50 PM

FDA will apply a so-called emergency use authorization-plus standard to COVID-19 vaccine review that leans closer to requirements for a full biologics license application, agency biologics center chief Peter Marks said Thursday (Sept. 10).


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.